Drug therapy problem in the pharmacotherapeutic follow-up of patients with tuberculosis, HIV/AIDS and in co-infection: integrative review
DOI:
https://doi.org/10.33448/rsd-v11i4.27424Keywords:
Tuberculosis; HIV; Pharmaceutical Care; AIDS; Co-infection.Abstract
Pharmaceutical care is the responsible provision of pharmacotherapy and aims to achieve defined outcomes that improve quality of life. Tuberculosis, HIV/AIDS and co-infected patients use a large amount of medication, which increases the risk of having drug therapy problems. The objective of this study was to verify the evidence available in the literature on drug therapy problems in the pharmacotherapeutic follow-up of patients receiving treatment for tuberculosis, HIV/AIDS and in co-infection. This is an integrative literature review study, searching for articles in the latin american literature in science and Health and PubMed databases. Eighteen articles related to the topic were selected. Regarding the methodology, eight used the Dader method, seven the pharmacist’s workup of drug therapy and three used other methods of classification of drug therapy problems. Positive results were found when pharmaceutical guidance was applied to patient care, identifying a lower occurrence of drug therapy problem when there was an intervention of the pharmacist with the clinical team. It was observed that most drug therapy problem reported were related to drug safety, followed by indication. These studies reinforce the idea that pharmaceutical intervention can reduce the number of drug therapy problem and increase the quality patients’ care.
References
Abah, I. O., Ojeh V. B., KD, Falang, K. D., Darin K. M., Olaitan, O. O. & Agbaji, O. O. (2014). Pharmaceutical care outcomes in an outpatient human immunodeficiency virus treatment center in Jos, Nigeria. Journal of basic and clinical pharmacy, 5(3), 57-61.
Aizenstein, M. L. & Tomassi, M. H. (2011) Problemas relacionados a medicamentos; reações adversas a medicamentos e erros de medicação: a necessidade de uma padronização nas definições e classificações Rev Ciênc Farm Básica Apl., 32(2):169-173.
Bernal, F., Vásquez, P., Rodríguez, L., Gavrilovics, A., & Serri, M. (2015). Seguimiento farmacoterapéutico de pacientes chilenos con infección por VIH/SIDA hospitalizados en un centro de alta complejidad durante un período de un año. Rev. chil. infectol, 32(1), 50-56.
Brasil. (2019). Ministério da Saúde. Manual de Recomendações para o Controle da Tuberculose no Brasil. Brasília: Ministério da Saúde.
Cipolle, R. J., Strand, L. M.; & Morley, P. C. (1998) Pharmaceutical Care Practice. McGraw-Hill.
Cipolle, R. J., Strand, L. M., & Morley, P. C. (2012). Pharmaceutical Care Practice: The Patient-Centered Approach to Medication Management Services. New York: McGraw-Hill Medical Publishing.
Comité de Consenso (2007). Tercer Consenso de Granada sobre problemas relacionados con los medicamentos (PRM) y resultados negativos asociados a la medicación (RNM). Ars. Pharm ;48:5-17.
Foisy, M. M., & Akai, P. S. (2004). Pharmaceutical care for HIV patients on directly observed therapy. The Annals of pharmacotherapy, 38(4), 550-556.
Hernández D. S., Castro M. M. S. & Dáder M. J. F. Método Dáder. Manual de Seguimento Farmacoterapêutico, 2014, versão em português do Brasil. Grupo de Investigación en Atención Farmacéutica (CTS-131). Universidad de Granada. (3a ed.).
Lopes, A. R. V., Miranda, S. S., Ceccato, M. G. B, Silveira, M. R., Resende, N. H., & Carvalho, W. S. (2017). Evaluation of the impact of pharmaceutical care for tuberculosis patients in a Secondary Referral Outpatient Clinic, Minas Gerais, Brazil. An. acad. bras. ciênc, 89(4), 2911-2919.
Loureiro, C. V., Reis, H. P. L. C, Magalhães, K. N., Carmo, C. P., Leite, F. A. M., Passos, A. C. B, Firmino, P. I. M., Kheir, N, Woods, D. J., Ponciano A. M. S. & Fonteles, M. M. F. (2012). Quality of life of HIV+ patients undergoing pharmacotherapeutic follow-up. Braz. j. pharm. sci, 48(4), 711-718.
Methley, A. M., Campbell S., Chew-Graham, C., McNally, R. & Cheraghi-Sohi, S. (2014) PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews. BMC Health Services Research, 14:579
Meintjes, G., Brust J. C. M., Nuttall J., Maartens G. (2019). Management of active tuberculosis in adults with HIV Lancet HIV, 6(7): 463–474.
Molino, C. G. R. C, Carnevale, R. C., Rodrigues, A. T., Visacri, M. B., Moriel, & Mazzola, P. G. (2014). Impact of pharmacist interventions on drug-related problems and laboratory markers in outpatients with human immunodeficiency virus infection. Therapeutics and clinical risk management, 10, 631-639.
Molino, C. G. R. C., Carnevale R. C., Rodrigues A. T., Moriel P., & Mazzola, P. G. (2017). HIV pharmaceutical care in primary healthcare: Improvement in CD4 count and reduction in drug-related problems. Saudi pharmaceutical jornal. SPJ: the official publication of the Saudi Pharmaceutical Society, 25(5), 724-733.
Moya, Y., Bernal F., Rojas, E, & Barthel, E. (2012). Seguimiento fármaco-terapéutico en pacientes ambulatorios con tratamiento anti-retroviral. Rev. chil. infectol, 29(4), 412-419.
Neves L. A. S., Canini S. E. M., Reis R. K., Santos C. B. & Gir E. (2012) Aids e tuberculose: a coinfecção vista pela perspectiva da qualidade de vida dos indivíduos. Rev Esc Enferm USP; 46(3):704-10.
Ojeh V. B., Naima N., Abah, I. O., Falang, K. D., Lucy O., London, I, Dadi C., Agaba P. & Agbaji, O. (2015). Pattern of drug therapy problems and interventions in ambulatory patients receiving antiretroviral therapy in Nigeria. Pharmacy practice, 13(2), 566.
Oliboni L. S. & Castro M. S. Adesão à farmacoterapia, que universo é esse? Uma revisão narrativa. (2018) Clin Biomed Res;38(2)
Ouzzani M., Hammady H., Fedorowicz Z & Elmagarmid A. (2016) Rayyan-a web and mobile app for systematic reviews. Syst Rev 5(1):210.
Page M. J., McKenzie J. E., Bossuyt P. M., Boutron I., Hoffmann T. C., Mulrow C. D., et al. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ;372:n71.
Pharmaceutical Care Network Europe (2021). PCNE Working group on drug-related problems. <https://www.pcne.org/working-groups/2/drug-related-problem-classification>
Prado C. G., Podesta, M. H. C. M., Souza, L. P. T, Souza, W. A. & Ferreira, E. B. (2016) Pharmacoterapeutic follow-up of HIV-positive patients at a Dispensing Antiretroviral Medicines Unit. Revista da Universidade Vale do Rio Verde; 14(2):562-576.
Ramalho de Oliveira D., Brummel A.R., Miller D.B. Medication therapy management: 10 years of experience in a large integrated health care system (2010). J Manag Care Pharm, 16(3):185-95.
Ramalho de Oliveira, D (2011). Atenção Farmacêutica: da filosofia ao gerenciamento da terapia medicamentosa. RCN.
Reis, H. P. L. C, Magalhães, K. N., Loureiro, C. V, Carmo, C. P., Ponciano, A. M. S., & Fonteles, M. M. F. (2014). Care plan for HIV+ patients in specialized Aids centers in Brazil: Pharmacotherapeutic form and pilot study. Acta sci., Health sci, 36(1), 91-96.
Resende N. H., Souza J. A., Martins U. C., Reis, A. M., Miranda S. S., Carvalho, W. S. (2021). Medication therapy management in patients with tuberculosis and HIV/AIDS: case series. Rev Bras Farm Hosp Serv Saude, 12(4):0681.
Resende, N. H., Miranda, S. S., Ceccato, M. G. B, Haddad, J. P. A, Reis, A. M. M, Silva, D. I & Carvalho, W. S. (2019). Drug therapy problems for patients with tuberculosis and HIV/AIDS at a reference hospital. Einstein (Säo Paulo), 17(4), eAO4696-eAO4696.
Rocha B. S., Silveira M. P. T., Moraes C. G., Kuchenbecker R. S. & Dal-Pizzol T. S. (2015) Pharmaceutical interventions in antiretroviral therapy: systematic review and meta-analysis of randomized clinical trials. Journal of Clinical Pharmacy and Therapeutics, 40, 251–258.
Rodrigues I. L. A., Monteiro L. L., Pacheco R. H. B., Silva S. E. D. (2010) Abandono do tratamento de tuberculose em co-infectados TB/HIV. Rev Esc Enferm; 44(2):383-7.
Romeu, G. A., Paiva, L. V. & Fé, M. M. M. (2009). Pharmaceutical care to pregnant women carrying human immunodeficiency virus. Braz. j. pharm. sci, 45(3), 593-602.
Santos, A. C, Pereira, D. A, Silva, O. A, & Lopes, L. C. (2006). Seguimento farmacoterapêutico em pacientes com tuberculose pulmonar através da Metodologia Dáder. Rev. ciênc. farm. básica apl, 27(3), 269-273.
Silveira M. P. T., Guttier M. C., Page K. & Moreira L. B (2013). Randomized controlled trial to evaluate the impact of pharmaceutical care on therapeutic success in HIV-infected patients in Southern Brazil. AIDS and behavior, 18, S75-84.
Soeiro, V. M. S, Caldas, A. J. M. C., Ferreira, T. F. (2020). Abandono Do Tratamento Da Tuberculose No Brasil, 2012-2018: Tendência E Distribuição Espaço-Temporal. Cien Saude Colet. Retrieved from: http://www.cienciaesaudecoletiva.com.br/artigos/abandono-do-tratamento-da-tuberculose-no-brasil-20122018-tendencia-e-distribuicao-espacotemporal/17871?id=17871
Verdugo, R. M, Conde, M. T. M., Merino M. P. V, Uranga A. I, Cerdá J. M. V, de las Hazas J. S. R, Paniagua S. P., Barrueta O. I., Sanchez C. M., Valín L. O., Palacín A. F., Gonzáles C. A. (2012). Development and validation of a prediction model to identify HIV+ patients with drug-related problems. A prediction study. Farmacia Hospitalaria, 36(5):343-350.
Viegas A. M., Miranda S. S, Haddad, J. P., Ceccato M. G., Carvalho W. S. (2017). Association of outcomes with comprehension, adherence and behavioral characteristics of tuberculosis patients using fixed-dose combination therapy in Contagem, Minas Gerais, Brazil. Rev Inst Med Trop São Paulo.;59:e28
Whittemore, R.; Knafl, K. The integrative review: updated methodology. J Adv Nursv. 52, 546-53, 2005.
WHO - World Health Organization (2021) Global Tuberculosis Report. <https://www.who.int/publications/i/item/9789240037021>
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Natália Helena de Resende; Deyverson Juan Mendes Lopes; Ursula Carolina de Morais Martins; Adriano Max Moreira Reis; Silvana Spíndola de Miranda; Wânia da Silva Carvalho
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
